Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Generic Musculoskeletal Disorders Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global generic musculoskeletal disorders drugs market is expected to grow from $0.05 billion in 2022 to $0.06 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The generic musculoskeletal disorders drugs market is expected to grow to $0.07 billion in 2027 at a CAGR of 5.7%.
Major players in the generic musculoskeletal disorders drugs market are Pfizer Inc., Sanofi S.A., Eli Lilly And Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca Plc., Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics Plc., Procter & Gamble, Eisai Co. Ltd., Biogen Inc., and Sino Biopharmaceutical Limited.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Generic musculoskeletal disorders drugs refer to the medication that plays a key role in managing musculoskeletal condition. They are used to relieve pain and stiffness in muscles and treat muscle spasms.
The main treatment of generic musculoskeletal disorders drugs are medication, therapy, surgery, and others. Medication refers to a dose form with one or more active chemicals as well as potential inactive ones. These can be administered through oral, parenteral, and other routes for the treatment of osteoarthritis, rheumatoid arthritis, spondylarthritis, juvenile idiopathic arthritis, psoriatic arthritis, fibromyalgia, and other disorders. These are distributed via various channels such as hospital pharmacy, retail pharmacy, drug store, and online pharmacy.
Strategic partnerships are a key trend gaining popularity in the generic musculoskeletal disorders drugs market. Many companies operating in the generic musculoskeletal disorders drugs market are undergoing partnerships to strengthen their position in the market.
In February 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, partnered with Alex Therapeutics, a Sweden-based digital therapeutics company. This new strategic business relationship offers patients evidence-based, clinically verified, and tailored digital therapeutics.
In May 2020, Assertio Therapeutics Inc., a US-based specialty pharmaceutical company acquired Zyla Life Sciences for an undisclosed deal amount. With this acquisition, Assertio Therapeutics aims to focus on neurology, inflammation, and pain products, an assortment of non-steroidal anti-inflammatory medicines that are distinct. Zyla Life Sciences is a US-based producer and distributor of anti-inflammatory and pain medications operating in the generic musculoskeletal disorders drugs market.
Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2022. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the generic musculoskeletal disorders drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The high prevalence of arthritis is expected to propel the growth of the generic musculoskeletal disorders drugs market going forward. Arthritis refers to the tenderness and swelling of joints along with the symptoms including joint pain and stiffness. Generic musculoskeletal disorders drugs help to relieve pain and stiffness in muscles and can treat muscle spasms in arthritis patients.
For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, by 2040, 78.4 million adults aged 18 years and older (25.9% of the total adult population) are expected to have doctor-diagnosed arthritis. Therefore, the high prevalence of arthritis is driving the growth of the generic musculoskeletal disorders drugs market.
The generic musculoskeletal disorders drugs market consists of sales of analgesics, oral non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-neuropathic pain medications, corticosteroids, and disease modifying anti-rheumatic drugs (DMARDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Key Topics Covered:
1. Executive Summary
2. Generic Musculoskeletal Disorders Drugs Market Characteristics
3. Generic Musculoskeletal Disorders Drugs Market Trends And Strategies
4. Generic Musculoskeletal Disorders Drugs Market - Macro Economic Scenario
4.1. COVID-19 Impact On Generic Musculoskeletal Disorders Drugs Market
4.2. Ukraine-Russia War Impact On Generic Musculoskeletal Disorders Drugs Market
4.3. Impact Of High Inflation On Generic Musculoskeletal Disorders Drugs Market
5. Generic Musculoskeletal Disorders Drugs Market Size And Growth
5.1. Global Generic Musculoskeletal Disorders Drugs Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Generic Musculoskeletal Disorders Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Generic Musculoskeletal Disorders Drugs Market Segmentation
6.1. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Medication
- Therapy
- Surgery
- Other Treatment Types
6.2. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Oral
- Parenteral
- Other Routes
6.3. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Disorder Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Osteoarthritis
- Rheumatoid Arthritis
- Spondylarthritis
- Juvenile Idiopathic Arthritis
- Psoriatic Arthritis
- Fibromyalgia
- Other Disorder Types
6.4. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Drug Store
- Online Pharmacy
7. Generic Musculoskeletal Disorders Drugs Market Regional And Country Analysis
7.1. Global Generic Musculoskeletal Disorders Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Generic Musculoskeletal Disorders Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/9gg814
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
